To Investigate Antihyperglycemic and Antihyperlipidemic Potential of Safrole in Rodents by in-vivo and in-vitro Study

S. Rani; S. Sharma; S. Kumar

doi:10.1055/s-0033-1357192

Drug Research, Inhaltsverzeichnis

Drug Res (Stuttg) 2014; 64(6): 287-295
DOI: 10.1055/s-0033-1357192

Original Article

To Investigate Antihyperglycemic and Antihyperlipidemic Potential of Safrole in Rodents by in-vivo and in-vitro Study

S. Rani

¹Division of Pharmacology, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Haryana, India

,

S. Sharma

¹Division of Pharmacology, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Haryana, India

,

S. Kumar

¹Division of Pharmacology, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Haryana, India

› Institutsangaben

Abstract

In the present investigation anti-diabetic and in-vitro antioxidant potential of safrole were evaluated (100 and 200 mg/kg p.o.) in acute and chronic Streptozotocin-nicotinamide (STZ) induced antihyperglycemic rat model. The oral administration of safrole for 30 days affects the level of blood glucose, glycosylated hemoglobin (HbA1C), total cholesterol (TC), triglycerides (TG), phospholipids, high density lipoprotein (HDL), body weight, insulin level, liver glycogen content, antioxidant parameters, lipase, α-amylase in normal and STZ induced diabetic rats. The oral administration of safrole at dose 100 & 200 mg/kg p.o. significantly improve the diabetic condition in Streptozotocin-induced diabetic rats. In enzymatic assay, the IC₅₀ value of the safrole for α-amylase and lipase was found to be 702.78 and 861.35 μg/ml respectively which was found comparable with the standard drug (ascorbic acid) as 252.12 μg/ml. Further studies can be performed on safrole for mechanistic and toxicological aspects so that it can be investigated as a new substance for the management of various diseases.

Key words

antihyperglycemic activity - streptozotocin - safrole - lipase - amylase

Volltext

Referenzen

References
1 Rother KI. Diabetes treatment – Bridging the Divide. N Engl J Med 356: 1499-1501
2 Betteridge J. Lipid disorders in diabetes mellitus. In: Pickup JC, Williams G. (eds.) Text Book of Diabetes. Blackwell Science Publishers; London: 1997: 1-35
3 Xu H, Blair NT, Clapham DE. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neur 2005; 25: 8924-8937
4 Jochen GW, Theis MD. Camphorated oil: still endangering the lives of Canadian children. Canadian Medical Association journal 1995; 152: 1821-1824
5 Inoue Y, Takeuchi S. Expectorant-like action of camphor derivatives. Nippon Ika Daigaku Zasshi 1969; 36: 351-354
6 Guilland-Cumming DF, Smith GJ. The effect of camphor on mitochondrial respiration. Experientia 1982; 38: 236-237
7 Goel HC, Roa AR. Radio sensitizing effect of camphor on transplantable mammary adenocarcinoma in mice. Canc Lett 1988; 43: 21-27
8 Akram J, Javed S, Ali AS et al. Effects of camphor oil on sexual behaviour in male rats. Iranian journal of pharmaceutical sciences 2006; 2: 209-214
9 Morsy TA, Rahem MA, El-Sharkawy EM et al. Eucalyptus globulus (camphor oil) against the zoonotic scabies, Sarcoptes scabiei. J Egypt Soc Parasit 2003; 33: 47-53
10 Sudha P, Smita SZ, Shobha YB et al. Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants. BMC Compl Alt Med 2011; 11: 5
11 Mukherjee M. Human digestive and metabolic lipases – a brief review. J Mol Catal B: Enzym 2003; 22: 369-376
12 Marudamuthu AS, Leelavinothan P. Effect of pterostilbene on lipids and lipid profiles in Streptozotocin – Nicotinamide induced type 2 diabetes mellitus. J Appl Biomed 2008; 6: 31-37
13 Kumar J, Sharma S, Kumar S. In-vivo anti-diabetic and antioxidant potential of Psoralea corylifolia seeds in STZ induced type-2 diabetic rats. J health sci 2011; 57: 225-235
14 Kumar S, Vasudena N, Sharma S. GC-MS analysis and screening of antidiabetic, antioxidant and hypolipidemic potential of Cinnamomum tamala oil in streptozotocin induced diabetes mellitus in rats. Cardiovas Diabetol 2012; 11: 95
15 Sedlak J, Lindsay RH. Estimation of total protein bound and non protein bound sulfhydryl group in tissue with ellman’s reagent. Anal Biochem 1968; 15: 192-205
16 Scifter S, Dayton S, Molic B et al. The estimation of glycogen with the anthrone reagent. In Archive Biochem 1950; 25: 191
17 Kumar S, Singh R, Vasudeva N et al. Acute and chronic animal models for the evaluation of anti-diabetic agents. Cardiovas Diabetol 2012; 11: 9
18 Xiao Z, Storms R, Tsang A. A quantitative starch-iodine method for measuring alpha-amylase and glucoamylase activities. Anal Biochem 2006; 351: 146-148
19 Yoshikawa M, Shimoda H, Nishida N et al. Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild anti-obesity effects in rats. J Nutr 2002; 132: 1819-1824
20 Han LK, Kimura Y, Okuda H. Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int J Obes 1999; 23: 174-179
21 Egesie UG, Adelaiye AB, Ibu JO et al. Safety and hypoglycemic properties of aqueous leave extract of Ocimum gratissium in streptozotocin induced diabetic rabbits. Nig J Physiol Sci 2006; 21: 31-35
22 Ahmed I, Cummings E, Adeghate E et al. Beneficial effects and mechanism of action of Momordica charantia fruit juice in the treatment of streptozotocin-induced diabetes mellitus in rats. Mol Cell Biochem 2004; 26: 63-70
23 Sarkar S, Pranava M, Manita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacological Research 2007; 33: 1-4
24 Karunanayake EH, Jeevathayaparan S, Tennekoon KH. Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. J Ethnopharmacol 1990; 30: 199-204
25 Bailey CJ, Day C, Turner SL et al. Cerasee, a traditional treatment for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res 1985; 2: 81-84
26 Betteridge J. Lipid disorders in diabetes mellitus. In: Pickup JC, Williams G. (eds.) Text Book of Diabetes. Blackwell Science Publishers; London: 1997: 1-35
27 Taskinen M. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 1992; 41: 12-17
28 Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular level and the P.E. Fraction showed a moderate increase in GSHcomplications. Diab Car 1996; 19: 257-267
29 Song-Hwan B, Hyung-Joo S. Antioxidant activities of five different mulberry cultivars in Korea. LWT 2007; 40: 955-962
30 Pavana P, Sethupathy S, Santa K et al. Effects of Tephrosia purpurea aqueous seed extract on blood glucose and antioxidant enzyme activities in streptozotocin induced diabetic rats. Afr J Trad CAM 2009; 6: 78-86
31 Gallaher D, Schneeman BO. Nutritional and metabolic response to plant inhibitors of digestive enzymes. Adv Exp Med Biol 1986; 199: 167-184
32 Yasser B, Mohammad M, Mohammad H et al. Screening of Some Medicinal Plants for their Pancreatic Lipase Inhibitory Potential. Jord J Pharm Sci 2011; 4: 81